You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 153 No. 6, 22 MAR 1993 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Clinical Observations
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Adenine Phosphoribosyltransferase Deficiency With Renal Deposition of 2,8-Dihydroxyadenine Leading to Nephrolithiasis and Chronic Renal Failure

Kenneth H. Fye, MD; Amrik Sahota, PhD; Douglas C. Hancock, MD; Arnold B. Gelb, MD; Ju Chen, MS; Joel W. Sparks, PhD; Richard K. Sibley, MD; Jay A. Tischfield, PhD

Arch Intern Med. 1993;153(6):767-770.


Abstract



Homozygous adenine phosphoribosyltransferase deficiency is a genetic defect that is associated with 2,8-dihydroxyadenine urolithiasis. Since the prevalence of the heterozygous state is found in 0.4% to 1.2% of the population, it is surprising that more cases of 2,8-dihydroxyadenine urolithiasis have not been reported. Herein we describe a patient with complete adenine phosphoribosyltransferase deficiency with 2,8-dihydroxyadenine urolithiasis leading to chronic renal failure. Gene sequencing revealed that the patient is a compound heterozygote. One of the mutations (a T insertion between bases 346 and 347) has been encountered before, but the second (a G-to-A substitution at base 1356) has not been previously reported. Possible explanations for the unexpected rarity of 2,8-dihydroxyadenine urolithiasis are discussed.

(Arch Intern Med. 1993;153:767-770)



Author Affiliations



From the Department of Medicine, University of California Medical School, San Francisco (Drs Fye and Hancock), the Department of Pathology, Stanford (Calif) University Hospital (Drs Gelb and Sibley), the Department of Geology, Stanford University (Dr Sparks), and the Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis (Drs Sahota and Tischfield and Mr Chen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vascular Calcification in Chronic Renal Failure: What Have We Learned From Animal Studies?
Neven and D'Haese
Circ. Res. 2011;108:249-264.
ABSTRACT | FULL TEXT  

Phenotype and Genotype Characterization of Adenine Phosphoribosyltransferase Deficiency
Bollee et al.
J. Am. Soc. Nephrol. 2010;21:679-688.
ABSTRACT | FULL TEXT  

Is adenine phophorybosiltransferase deficiency a still underdiagnosed cause of urolithiasis and chronic renal failure? A report of two cases in a family with an uncommon novel mutation
Perruzza et al.
Clin Kidney J 2008;1:292-295.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.